Evidence map›Paper›PMID 23942622›Full record

ArticleTranslational psychiatry2013

The effects of congenital brain serotonin deficiency on responses to chronic fluoxetine.

B D Sachs, J P R Jacobsen, T L Thomas, W B Siesser, W L Roberts, M G Caron

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Novel aspects of enteric serotonergic signaling in health and brain-gut disease.American journal of physiology. Gastrointestinal and liver physiology · 2020
    Review
  12. Slow-release delivery enhances the pharmacological properties of oral 5-hydroxytryptophan: mouse proof-of-concept.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

B D SachsDepartment of Cell Biology, Duke University, Durham, NC 27710, USA.
J P R Jacobsen
T L Thomas
W B Siesser
W L Roberts
M G Caron
Duke University · US

Funding

Recruitment and Assessment Core Patient RecruitmentP50MH060451 · NIMH · DUKE UNIVERSITY · PI STEFFENS, DAVID C. · 2001 to 2010
$22.3M
The 5-HT theory of depression tested in a naturalistic model of 5-HT deficiencyR01MH079201 · NIMH · DUKE UNIVERSITY · PI CARON, MARC G. · 2007 to 2016
$3.7M
The Effects of 5-HT Deficiency on Responses to Stress and Antidepressant DrugsF32MH093092 · NIMH · DUKE UNIVERSITY · PI SACHS, BENJAMIN D · 2010 to 2013
$160k
Effects of chronic antidepressants on mice with a mutation in Tph2F32MH083404 · NIMH · DUKE UNIVERSITY · PI SIESSER, WILLIAM BOURCHIER · 2008 to 2009
$86k
NIMH NIH HHS F32 MH083404NIMH NIH HHS F32-MH-083404NIMH NIH HHS F32 MH093092NIMH NIH HHS F32-MH093092NIMH NIH HHS MH60451NIMH NIH HHS MH79201NIMH NIH HHS MH79201-03S1NIMH NIH HHS P50 MH060451NIMH NIH HHS R01 MH079201
6 · The paper itself

Abstract

The importance of reversing brain serotonin (5-HT) deficiency and promoting hippocampal neurogenesis in the mechanisms of action for antidepressants remain highly controversial. Here we examined the behavioral, neurochemical and neurogenic effects of chronic fluoxetine (FLX) in a mouse model of congenital 5-HT deficiency, the tryptophan hydroxylase 2 (R439H) knock-in (Tph2KI) mouse. Our results demonstrate that congenital 5-HT deficiency prevents a subset of the signature molecular, cellular and behavioral effects of FLX, despite the fact that FLX restores the 5-HT levels of Tph2KI mice to essentially the levels observed in wild-type mice at baseline. These results suggest that inducing supra-physiological levels of 5-HT, not merely reversing 5-HT deficiency, is required for many of the antidepressant-like effects of FLX. We also demonstrate that co-administration of the 5-HT precursor, 5-hydroxytryptophan (5-HTP), along with FLX rescues the novelty suppressed feeding (NSF) anxiolytic-like effect of FLX in Tph2KI mice, despite still failing to induce neurogenesis. Thus, our results indicate that brain 5-HT deficiency reduces the efficacy of FLX and that supplementation with 5-HTP can restore some antidepressant-like responses in the context of 5-HT deficiency. Our findings also suggest that feeding latency reductions in the NSF induced by chronic 5-HT elevation are not mediated by drug-induced increments in neurogenesis in 5-HT-deficient animals. Overall, these findings shed new light on the impact of 5-HT deficiency on responses to FLX and may have important implications for treatment selection in depression and anxiety disorders.

Indexed as

5-HydroxytryptophanAnimalsAntidepressive Agents, Second-GenerationAnxietyBehavior, AnimalFeeding BehaviorFluoxetineHippocampusMiceMice, TransgenicMicrodialysisNeurogenesisSelective Serotonin Reuptake InhibitorsSerotoninTryptophan Hydroxylase5-HydroxytryptophanAntidepressive Agents, Second-GenerationFluoxetineSelective Serotonin Reuptake InhibitorsSerotoninTph2 protein, mouseTryptophan Hydroxylase

Identifiers

PMID23942622
PMCPMC3756292
OpenAlexW2057588533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.